Decreased expression of fas (CD95/AP01)associated with goblet cell metaplasia in barrett's esophagus

This publication has 33 references indexed in Scilit:

• Biochemical Mechanisms of IL-2–Regulated Fas-Mediated T Cell Apoptosis
  Published by Elsevier ,1998
• The host—tumor immune conflict: from immunosuppression to resistance and destruction
  Immunology Today, 1997
• Epression of the Apoptosis-Inducing FAS Ligand (FASL) in Human First and Third Trimester Placenta and Choriocarcinoma Cells
  Journal of Clinical Endocrinology & Metabolism, 1997
• Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape
  Science, 1996
• Prevention of Islet Allograft Rejection with Engineered Myoblasts Expressing FasL in Mice
  Science, 1996
• Tumor Necrosis Factor‐α Gene Transfer Augments Anti‐Fas Antibody‐mediated Apoptosis in Human Glioma Cells
  Japanese Journal of Cancer Research, 1996
• Fas and tumor necrosis factor receptor-mediated cell death: similarities and distinctions.
  The Journal of Experimental Medicine, 1994
• Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor family
  Cell, 1993
• The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
  Cell, 1991
• A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor.
  The Journal of Experimental Medicine, 1989